Physician profile
Christopher R Chuinard
NPI 1205926268
$1,442,178.89
in general payments reported to CMS, 2019-2025
20 companies · $422K in 2025
The $422K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147K · 2020: $192K · 2021: $153K · 2022: $161K · 2023: $207K · 2024: $159K · 2025: $422K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $548K · Consulting Fee: $202K · Travel and Lodging: $32K · Food and Beverage: $6,085 · Gift: $725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $547,936.60 |
| Consulting Fee | $202,200.00 |
| Travel and Lodging | $31,803.69 |
| Food and Beverage | $6,084.83 |
| Gift | $725.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $580,947.39 | 2019-2025 | Aequalis Perform, Tornier Perform Reversed Augmented Glenoid, Blueprint Patient Specific Instrumentation |
| Shoulder Innovations, INC. | $573,471.87 | 2019-2025 | Inset System |
| Wright Medical Technology, INC. | $232,433.97 | 2019-2020 | |
| Encore Medical, Lp | $48,883.39 | 2019-2022 | |
| Medical Device Business Services, INC. | $2,394.79 | 2019-2022 | |
| Depuy Synthes Products, INC. | $1,545.00 | 2019-2022 | |
| Azurmeds, INC. | $718.10 | 2021-2022 | |
| Catalyst Orthoscience | $451.73 | 2019-2021 | |
| Exactech, INC. | $372.12 | 2019-2021 | |
| Medacta USA, INC. | $294.48 | 2020-2022 | |
| Ossur Americas, INC. | $111.80 | 2024-2025 | Unloader One X, Miami J |
| Sunovion Pharmaceuticals INC. | $99.54 | 2019 | |
| Depuy Synthes Sales INC. | $99.34 | 2019 | |
| Surgalign Spine Technologies, INC. | $76.36 | 2019 | |
| Integrity Orthopaedics, INC. | $74.52 | 2024 | Integrity Orthopaedics |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $70.40 | 2025 | Biobrace 23mm, Conmed 3dhd Video Systems, Linvatec Shoulder Arthroscopy |
| Medwest Associates | $67.44 | 2022 | |
| Embody, INC. | $27.15 | 2023 | |
| Arthrex, INC. | $20.48 | 2021 | |
| Zimvie INC. | $19.02 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$68,300.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Chuinard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.